153 related articles for article (PubMed ID: 2899368)
1. Glucagon and glucose tolerance in liver cirrhosis.
Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin does not alter insulin-mediated glucose disposal.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
Meneilly GS; Minaker KL; Elahi D; Rowe JW
Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
[TBL] [Abstract][Full Text] [Related]
4. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
Nair KS
J Clin Endocrinol Metab; 1987 May; 64(5):896-901. PubMed ID: 2881943
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
Hamberg O; Vilstrup H
Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
[TBL] [Abstract][Full Text] [Related]
6. The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
Toft-Nielson M; Madsbad S; Holst JJ
Diabetes; 1996 May; 45(5):552-6. PubMed ID: 8621002
[TBL] [Abstract][Full Text] [Related]
7. Insulin, C-peptide and glucagon levels during OGTT in hepatic cirrhosis and in patients with prehepatic block.
Gerö L; Korányi L; Szalay F; Büki B; Tamás G
Acta Diabetol Lat; 1982; 19(1):55-64. PubMed ID: 7041501
[TBL] [Abstract][Full Text] [Related]
8. Circulating somatostatin concentrations in healthy and cirrhotic subjects.
Verrillo A; de Teresa A; Martino C; Pinto M; Golia R
Metabolism; 1986 Feb; 35(2):130-5. PubMed ID: 2868381
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin release in response to glucose is impaired in chronic renal failure.
Franceschini R; Robaudo C; Corsini G; Cataldi A; Bruno E; Russo R; Rolandi E; Barreca T
Biomed Pharmacother; 1998; 52(5):208-13. PubMed ID: 9755817
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.
Greco AV; Altomonte L; Ghirlanda G; Rebuzzi AG; Manna R; Bertoli A
Diabetologia; 1980 Mar; 18(3):187-91. PubMed ID: 6102941
[No Abstract] [Full Text] [Related]
12. Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
Barreca T; Franceschini R; Cataldi A; Rolandi E
J Hepatol; 1991 Jan; 12(1):40-4. PubMed ID: 1672540
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of the carbohydrate intolerance of cirrhosis.
Proietto J; Alford FP; Dudley FJ
J Clin Endocrinol Metab; 1980 Nov; 51(5):1030-6. PubMed ID: 6999005
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
Holst JJ; Burcharth F; Kühl C
Diabete Metab; 1980 Jun; 6(2):117-27. PubMed ID: 6997101
[TBL] [Abstract][Full Text] [Related]
16. Effect of difference in glucose infusion rate on quantification of hepatic glucose production.
Sheu WH; Hollenbeck CB; Wu MS; Jaspan JB; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1990 May; 70(5):1354-60. PubMed ID: 1970829
[TBL] [Abstract][Full Text] [Related]
17. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
[TBL] [Abstract][Full Text] [Related]
18. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Schmitz O
Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin enhances insulin-mediated glucose disposal in elderly subjects.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1988 Aug; 67(2):407-10. PubMed ID: 2899090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
